Ophthalmology

Article	Citations
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045	718
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data	428
International Classification of Retinopathy of Prematurity, Third Edition	283
Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients	277
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration	237
HAWK and HARRIER	210
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab	200
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab	194
Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study	164
Ocular Findings and Proportion with Conjunctival SARS-COV-2 in COVID-19 Patients	156
Primary Open-Angle Glaucoma Preferred Practice Pattern®	153
Photovoltaic Restoration of Central Vision in Atrophic Age-Related Macular Degeneration	149
Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration	145
Genetic Basis of Inherited Retinal Disease in a Molecularly Characterized Cohort of More Than 3000 Families from the United Kingdom	129
Multifocal and Extended Depth-of-Focus Intraocular Lenses in 2020	119
Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic	112
Update on Intraocular Lens Power Calculation Study Protocols	107
Polypoidal Choroidal Vasculopathy	101
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration	100
Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis	99
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration	97
The Risks and Benefits of Myopia Control	96
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma	94
Application of Automated Quantification of Fluid Volumes to Anti–VEGF Therapy of Neovascular Age-Related Macular Degeneration	92
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease	89

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)	89
Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children	89
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset	85
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout	82
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19	81
Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure	80
COVID-19 Quarantine Reveals That Behavioral Changes Have an Effect on Myopia Progression	78
Ganglion Cell Complex Thickness and Macular Vessel Density Loss in Primary Open-Angle Glaucoma	75
Prevalence of Keratoconus Based on Scheimpflug Imaging	72
Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty	72
Intraocular Lens Power Formulas, Biometry, and Intraoperative Aberrometry	71
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration	70
Intraocular Lens Implantation in the Absence of Zonular Support: An Outcomes and Safety Update	69
Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2	69
Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration	66
Academic Ophthalmology during and after the COVID-19 Pandemic	65
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment	65
Primary Retinal Detachment Outcomes Study Report Number 2	64
Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning	63
Randomized Clinical Trial Comparing Femtosecond LASIK and Small-Incision Lenticule Extraction	62
Evolution of the Prevalence of Myopia among Taiwanese Schoolchildren	61
Trends in Glaucoma Surgeries Performed by Glaucoma Subspecialists versus Nonsubspecialists on Medicare Beneficiaries from 2008 through 2016	61
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)	61
The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment	60
Comparison of Myopic Progression before, during, and after COVID-19 Lockdown	59
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children	57
Socioeconomic and Demographic Disparities in the Use of Telemedicine for Ophthalmic Care during the COVID-19 Pandemic	55
Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children	55
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy	54
Increased Time Outdoors Is Followed by Reversal of the Long-Term Trend to Reduced Visual Acuity in Taiwan Primary School Students	53
Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT	53
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis	52
Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration	51
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease	50
Time Outdoors in Reducing Myopia	50
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial	50
Three-Year Findings of the HORIZON Trial	49
Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia	49
Cataract in the Adult Eye Preferred Practice Pattern®	49
Updating the Staging System for Diabetic Retinal Disease	49
Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen	48
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe	48
Detection of Progressive Glaucomatous Optic Nerve Damage on Fundus Photographs with Deep Learning	48
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery	47
Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom	47
Primary Angle-Closure Disease Preferred Practice Pattern®	47
Longitudinal Macular Structure–Function Relationships in Glaucoma	47
The Bidirectional Relationship between Vision and Cognition	47
Multifocal and Accommodating Intraocular Lenses for the Treatment of Presbyopia	46
Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients	46

Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma	46
The State of Ophthalmology Medical Student Education in the United States: An Update	45
Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic	45
Autologous Retinal Transplantation for Primary and Refractory Macular Holes and Macular Hole Retinal Detachments	45
Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study	45
The Economic Burden of Vision Loss and Blindness in the United States	45
Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration	44
OCT Angiography for the Diagnosis of Glaucoma	44
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial	44
Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes	44
OCT Angiography Artifacts in Glaucoma	43
Intraocular Lens Power Calculations in Eyes with Previous Corneal Refractive Surgery	43
Assessing Glaucoma Progression Using Machine Learning Trained on Longitudinal Visual Field and Clinical Data	43
Anti–Vascular Endothelial Growth Factor Use and Atrophy in Neovascular Age-Related Macular Degeneration	43
Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine	43
Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy	42
Disparities in Vision Health and Eye Care	42
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2	42
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up	42
Foundational Considerations for Artificial Intelligence Using Ophthalmic Images	41
A Deep Learning Model for Segmentation of Geographic Atrophy to Study Its Long-Term Natural History	41
Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features	41
Global Retinoblastoma Treatment Outcomes	41
Evaluation of a Deep Learning–Derived Quantitative Retinopathy of Prematurity Severity Scale	41
Pseudophakic Dysphotopsia	41
Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT)	40
Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine	40
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1	40
Ranibizumab or Aflibercept for Diabetic Macular Edema	40
Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens	39
Seven-Year Follow-up of Gene Therapy for Leber’s Hereditary Optic Neuropathy	39
Uveitis in Juvenile Idiopathic Arthritis	39
Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children	39
American Academy of Ophthalmology Recommendations on Screening for Endogenous Candida Endophthalmitis	39
Risk of Systemic Adverse Events after Intravitreal Bevacizumab, Ranibizumab, and Aflibercept in Routine Clinical Practice	38
Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)	38
Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study	38
Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration	37
The Effect of Tube Location on Corneal Endothelial Cells in Patients with Ahmed Glaucoma Valve	37
Cost-Utility Analysis of Glaucoma Medication Adherence	37
Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes	37
The Global Extent of Undetected Glaucoma in Adults	36
Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus	36
An Intraocular Pressure Polygenic Risk Score Stratifies Multiple Primary Open-Angle Glaucoma Parameters Including Treatment Intensity	36
Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2	36
Recommendations for Standardization of Images in Ophthalmology	36
Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease	36
Ophthalmology Departments Remain Among the Least Diverse Clinical Departments at United States Medical Schools	36
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma	35
Intraocular Pressure, Glaucoma, and Dietary Caffeine Consumption	35
Anatomic Changes and Predictors of Angle Widening after Laser Peripheral Iridotomy	35
COVID-19 and the Ophthalmology Match	35
Prevalence and Pattern of Geographic Atrophy in Asia	35
The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study	34
Endophthalmitis Rate in Immediately Sequential versus Delayed Sequential Bilateral Cataract Surgery within the Intelligent Research in Sight (IRIS®) Registry Data	34
A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma	34
Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality	34
Multimodal Machine Learning Using Visual Fields and Peripapillary Circular OCT Scans in Detection of Glaucomatous Optic Neuropathy	33
Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema	33
Biallelic CPAMD8 Variants Are a Frequent Cause of Childhood and Juvenile Open-Angle Glaucoma	33
Predicting Progression to Advanced Age-Related Macular Degeneration from Clinical, Genetic, and Lifestyle Factors Using Machine Learning	33
Artificial Intelligence Classification of Central Visual Field Patterns in Glaucoma	33
Intravitreal Pharmacotherapies for Diabetic Macular Edema	32
Small-Incision Lenticule Extraction (SMILE) for the Correction of Myopia with Astigmatism	32
Bilateral Same-Day Cataract Surgery: An Idea Whose Time Has Come #COVID-19	32
Longitudinal Changes and Predictive Value of Choroidal Thickness for Myopia Control after Repeated Low-Level Red-Light Therapy	32
Genotypic and Phenotypic Spectrum of Foveal Hypoplasia	32
Demographics of a Large International Population of Patients Affected by Leber’s Hereditary Optic Neuropathy	32
Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area	32
Characteristics of Orbital Floor Fractures in the United States from 2006 to 2017	32
X-Linked Retinoschisis	31
The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections	31
Authorship Gender Composition in the Ophthalmology Literature from 2015 to 2019	31
Autosomal Recessive Bestrophinopathy	31
Development of a Genotype Assay for Age-Related Macular Degeneration	30
Management and Outcomes for Neovascular Age-Related Macular Degeneration	30
Characterization of Facial Trauma Associated with Standing Electric Scooter Injuries	30
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid	29
Immune Checkpoint Inhibitor-Associated Optic Neuritis	29
COVID-19 and Use of Teleophthalmology (CUT Group): Trends and Diagnoses	29

Profiles of Ganglion Cell-Inner Plexiform Layer Thickness in a Multi-Ethnic Asian Population	29
How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country	29
Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019	29
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis	29
Gender Compensation Gap for Ophthalmologists in the First Year of Clinical Practice	29
Diabetic Retinopathy Screening Using Smartphone-Based Fundus Imaging in India	28
Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry	28
Neurodevelopmental Outcomes after Bevacizumab Treatment for Retinopathy of Prematurity	28
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration	28
DeepLensNet: Deep Learning Automated Diagnosis and Quantitative Classification of Cataract Type and Severity	28
Coping with COVID-19: An Italian Perspective on Corneal Surgery and Eye Banking in the Time of a Pandemic and Beyond	28
Transepithelial versus Epithelium-off Corneal Collagen Cross-linking for Corneal Ectasia	28
Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®	28
Myopia Prevalence and Ocular Biometry Features in a General Japanese Population	27
Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer Loss in a Large Clinical Population	27
Intraocular Lenses	27
Beyond Performance Metrics	27
Symptomatic COVID-19 in Eye Professionals in Wuhan, China	27
Interventions for the Management of Computer Vision Syndrome	27
Time-Course Changes in Optic Nerve Head Blood Flow and Retinal Nerve Fiber Layer Thickness in Eyes with Open-angle Glaucoma	27
Postoperative Endophthalmitis in Immediate Sequential Bilateral Cataract Surgery	27
Prevalence of Strabismus and Its Impact on Vision-Related Quality of Life	26
Accuracy of Autorefraction in Children	26
Interventions for Indirect Traumatic Optic Neuropathy	26
Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration	26
Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US	26
Ocular Symptoms among Nonhospitalized Patients Who Underwent COVID-19 Testing	26
Lighting a Pathway: The Minority Ophthalmology Mentoring Program	25
Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis	25
Vaccine-Associated Uveitis after COVID-19 Vaccination	25
Living with COVID-19: A Perspective from New York Area Ophthalmology Residency Program Directors at the Epicenter of the Pandemic	25
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries	25
Aggressive Posterior Retinopathy of Prematurity	25
Teprotumumab	25
Explaining the Rationale of Deep Learning Glaucoma Decisions with Adversarial Examples	24
Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata	24
Artificial Intelligence for Retinopathy of Prematurity	24
Value of 10-2 Visual Field Testing in Glaucoma Patients with Early 24-2 Visual Field Loss	24
Association of Antihypertensive Medication with Retinal Nerve Fiber Layer and Ganglion Cell-Inner Plexiform Layer Thickness	24
Cardiovascular Disease Predicts Structural and Functional Progression in Early Glaucoma	24
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration	24
Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma	24
Matching the Patient to the Intraocular Lens	23
A Comparison of the Accuracy of 6 Modern Toric Intraocular Lens Formulas	23
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis	23
Intense Pulsed Light for Meibomian Gland Disease	23
Intraocular Lens Power Calculation in Eyes with Previous Excimer Laser Surgery for Myopia	23
Characteristics of p.Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank	23
Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration	23
Patient Harm Due to Diagnostic Error of Neuro-Ophthalmologic Conditions	23
Digital Gonioscopy Based on Three-dimensional Anterior-Segment OCT	23
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma	23
Intraocular Lens Complications	23
Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery	23
Vision Impairment and Blindness Prevalence in the United States	22
Blood Pressure and Glaucomatous Progression in a Large Clinical Population	22
Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening	22
NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction	22
Effectiveness of an Ophthalmic Hospital-Based Virtual Service during the COVID-19 Pandemic	22
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment	22
Childhood and Early Onset Glaucoma Classification and Genetic Profile in a Large Australasian Disease Registry	22
Importance of Paravascular Vitreal Adhesions for Development of Myopic Macular Retinoschisis Detected by Ultra-Widefield OCT	22
A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity	22
Face Masks and Bacterial Dispersion Toward the Periocular Area	22
Age-Related Eye Disease and Cognitive Function	22
Challenges and Lessons for Managing Glaucoma during COVID-19 Pandemic: Perspectives from Asia	22
Genome-Wide Association Study in Asians Identifies Novel Loci for High Myopia and Highlights a Nervous System Role in Its Pathogenesis	22
OCT Angiography Findings in Preclinical Alzheimer’s Disease: 3-Year Follow-Up	22
Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma	22
Machine Learning Approach for Intraocular Disease Prediction Based on Aqueous Humor Immune Mediator Profiles	21
Prevalence Trend of Myopia after Promoting Eye Care in Preschoolers	21
Retinal Nerve Fiber Layer Thickness in Healthy Eyes of Black, Chinese, and Latino Americans	21
Smartphone Use Associated with Refractive Error in Teenagers	21
X-Linked Retinoschisis	21
Using Social Media to Disseminate Ophthalmic Information during the #COVID19 Pandemic	21
Future Intraocular Lens Technologies	21
Glaucoma-like Parapapillary Choroidal Microvasculature Dropout in Patients with Compressive Optic Neuropathy	21
Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema	21
Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels	21
Ophthalmic Medication Expenditures and Out-of-Pocket Spending	21
Patterns of Daily Physical Activity across the Spectrum of Visual Field Damage in Glaucoma Patients	20
Implementing and Monitoring At-Home Virtual Reality Oculo-kinetic Perimetry During COVID-19	20
Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial	20
Relationship between Three-Dimensional Magnetic Resonance Imaging Eyeball Shape and Optic Nerve Head Morphology	20
Differentiation of Active Corneal Infections from Healed Scars Using Deep Learning	20
In Pursuit of the Elimination of Corneal Blindness: Is Establishing Eye Banks and Training Surgeons Enough?	20
Reporting Guidelines for Artificial Intelligence in Medical Research	20
Impact of Standardized Prescribing Guidelines on Postoperative Opioid Prescriptions after Ophthalmic Surgery	20
Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging	20
Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence–Enabled Dashboard	20
Deep Learning Estimation of 10-2 and 24-2 Visual Field Metrics Based on Thickness Maps from Macula OCT	20
Alcohol, Intraocular Pressure, and Open-Angle Glaucoma	20
The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1	20
Comparison of 10-2 and 24-2C Test Grids for Identifying Central Visual Field Defects in Glaucoma and Suspect Patients	20
Inflammation after Voretigene Neparvovec Administration in Patients with RPE65-Related Retinal Dystrophy	19